Will Helicobacter pylori be the next organism for which we will have exhausted our treatment options?
Hazell
S L
SL
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000494:pharmacology / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000382:microbiology; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D018942:Macrolides; D009593:Nitroimidazoles / Q000494:pharmacology / Q000627:therapeutic use; D017211:Treatment Failure
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D018942:Macrolides; D009593:Nitroimidazoles